Basic components of connective tissues and extracellular matrix: Elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins

Advances in Experimental Medicine and Biology

Volumn 802, Issue , 2014, Pages 31-47

  Halper, Jaroslava ^a   Kjaer, Michael ^b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Elastin; Fibrillin; Fibulins; Laminin; Tenascins

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; CELL SURFACE RECEPTOR; COLLAGEN; ELASTIN; FIBRILLIN; FIBRIN; FIBRINOGEN; FIBRONECTIN; FIBULIN; GLYCOPROTEIN; INTEGRIN; LAMININ; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; TENASCIN; THROMBIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; TROPOELASTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR; FIBRILLIN 1; FIBULIN 5; FOCAL ADHESION KINASE; GELATINASE B; INTERLEUKIN 1; INTERSTITIAL COLLAGENASE; PLATELET DERIVED GROWTH FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNINDEXED DRUG; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 2;

APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOCHEMISTRY; BLOOD CLOTTING; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE; CUTIS LAXA; EHLERS DANLOS SYNDROME; ELASTIC FIBER; EXTRACELLULAR MATRIX; GENE MUTATION; HEART DISEASE; HUMAN; INTRACELLULAR SIGNALING; KELOID; MARFAN SYNDROME; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SCAR; SCLERODERMA; SOFT TISSUE DISEASE; SYSTEMIC SCLEROSIS; TISSUE REGENERATION; CARBOXY TERMINAL SEQUENCE; CELL TRANSPORT; ENZYME ACTIVATION; FIBRINOGEN SYNTHESIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF;

CALCIUM-BINDING PROTEINS; CONNECTIVE TISSUE; ELASTIN; EXTRACELLULAR MATRIX; FIBRINOGEN; FIBRONECTINS; HUMANS; LAMININ; MICROFILAMENT PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TENASCIN; THROMBOSPONDINS;

EID: 84934438461     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-7-7893-1_3     Document Type: Article

References (145)

1. Kjaer M (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84:649-698
2. Leahy DJ, Aukhil I, Erickson HP (1996) 2.0 A crystal structure of a four-domain segment of human fi bronectin encompassing the RGD loop and synergy region. Cell 84:155-164
3. Potts JR, Campbell ID (1994) Fibronectin structure and assembly. Curr Opin Cell Biol 6:648-655
4. Sabatier L, Chen D, Fagotto-Kaufmann C, Hubmacher D, McKee MD, Annis DS, Mosher DF, Reinhardt DP (2009) Fibrillin assembly requires fi bronectin. Mol Biol Cell 20:846-858
5. Mao Y, Schwarzbauer J (2005) Fibronectin fi brillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24:389-399
6. Takahashi S, Leiss M, Moser M, Ohashi T, Kitao T, Heckmann D, Pfeifer A, Kessler H, Takagi J, Erickson HP, Fässler R (2007) The RGD motif in fi bronectin is essential for development but dispensable for fi bril assembly. J Cell Biol 178:167-178
7. Singh P, Schwarzbauer JE (2012) Fibronectin and stem cell differentiation - lessons from chondrogenesis. J Cell Sci 125:3703-3712
8. Dallas SL, Chen Q, Sivakumar P (2006) Dynamics of assembly and reorganization of extracellular matrix proteins. Curr Top Dev Biol 75:1-24
9. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E, Jones JCR, Kleinman HK, Marinkovich MP, Martin GR, Mayer U, Meneguzzi G, Miner JH, Miyazaki M, Patarroyo M, Paulsson M, Quaranta V, Sanes JR, Sasaki T, Sekiguchi K, Sorokin LM, Talts JF, Tryggvason K, Uitto J, Virtanen I, von Der Mark K, Wewer UM, Yamada Y, Yurchenco PD (2005) A simplifi ed laminin nomenclature. Matrix Biol 24:326-332
10. Miner JH, Yurchenco PD (2004) Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 20:255-284
11. Domogatskaya A, Rodin S, Tryggvason K (2012) Functional diversity of laminins. Annu Rev Cell Dev Biol 28:523-553
12. MacDonald PR, Lustig A, Steinmetz MO, Kammerer RA (2010) Laminin chain assembly is regulated by specifi c coiled-coil interactions. J Struct Biol 170:398-405
13. Grounds MD, Sorokin L, White J (2005) Strength at the extracellular matrix-muscle interface. Scand J Med Sci Sports 15:381-391
14. Taylor SH, Al-Youha S, Van Agtmael T, Lu Y, Wong J, McGrouther DA, Kadler KE (2011) Tendon is covered by a basement membrane epithelium that is required for cell retention and the prevention of adhesion formation. PLoS One 6:e16337
15. Molloy TJ, de Bock CE, Wang Y, Murrell GA (2006) Gene expression changes in SNAP-stimulated and iNOS-Transfected tenocytes-expression of extracellular matrix genes and its implications for tendonhealing. J Orthop Res 24:1869-1882
16. Sato N, Nakamura M, Chikama T, Nishida T (1999) Abnormal deposition of laminin and type IV collagen at corneal epithelial basement membrane during wound healing in Diabetic rats. Jpn J Ophthalmol 43:343-347
17. Della Corte A, De Santo LS, Montagnani S, Quarto C, Romano G, Amarelli C, Scardone M, De Feo M, Cotrufo M, Caianiello G (2006) Spatial patterns of matrix protein expression in Dilated ascending aorta with aortic regurgitation: Congenital bicuspid valve versus Marfan's syndrome. J Heart Valve Dis 15:20-27
18. Fish RJ, Neerman-Arbez M (2012) Fibrinogen gene regulation. Thromb Haemost 108:419-426
19. Doolittle RF, Goldbaum DM, Doolittle LR (1978) Designation of sequences involved in the coiled- coil' interdominal connections in fi brinogen: Constructions of an atomic scale model. J Mol Biol 120:311-325
20. Ariens RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ (2002) Role of factor XIII in fi brin clot formation and effects of genetic polymorphisms. Blood 100:743-754
21. Cilia La Corte AL, Philippou H, Ariëns RA (2011) Role of fi brin structure in thrombosis and vascular disease. Adv Protein Chem Struct Biol 83:75-127
22. Sahni A, Francis CW (2000) Vascular endothelial growth factor binds to fi brinogen and fi brin and stimulates endothelial cell proliferation. Blood 96:3772-3778
23. Sahni A, Odrljin T, Francis CW (1998) Binding of basic fi broblast growth factor to fi brinogen and fi brin. J Biol Chem 273:7554-7559
24. Clark RA, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB (1982) Fibronectin and fi brin provide a provisional matrix for epidermal cell migration During wound reepithelialization. J Invest Dermatol 79:264-269
25. Donaldson DJ, Mahan JT, Amrani D, Hawiger J (1989) Fibrinogen-mediated epidermal cell migration: Structural correlates for fi brinogen function. J Cell Sci 94:101-108
26. Armstrong PC, Peter K (2012) GPIIb/IIIa inhibitors: From bench to bedside and back to bench again. Thromb Haemost 107:808-814
27. Muiznieks LD, Weiss AS, Keeley FW (2010) Structural disorder and dynamics of elastin. Biochem Cell Biol 88:239-250
28. Mithieux SM, Wise SG, Weiss AS (2013) Tropoelastin - A multifaceted naturally smart material. Adv Drug Deliv Rev 65:421-428
29. Kielty CM (2006) Elastic fi bres in health and disease. Expert Rev Mol Med 8:1-23
30. Csiszar K (2001) Lysyl oxidases: A novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 70:1-32
31. Lee JE, Kim Y (2006) A tissue-specifi c variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specifi city. J Biol Chem 281:37282-37290
32. Kim YM, Kim EC, Kim Y (2011) The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin. Mol Biol Rep 38:145-149
33. Hinek A, Rabinovitch M (1994) 67-kD elastinbinding protein is a protective companion' of extracellular insoluble elastin and intracellular tropoelastin. J Cell Biol 126:563-574
34. Yeo GC, Keeley FW, Weiss AS (2011) Coacervation of tropoelastin. Adv Colloid Interface Sci 167:94-103
35. Kozel BA, Rongish BJ, Czirok A, Zach J, Little CD, Davis EC, Knutsen RH, Wagenseil JE, Levy MA, Mecham RP (2006) Elastic fi ber formation: A dynamic view of extracellular matrix assembly using timer reporters. J Cell Physiol 207:87-96
36. Berk DR, Bentley DD, Bayliss SJ, Lind A, Urban Z (2012) Cutis laxa: A review. J Am Acad Dermatol 66:842.e1-842.e17
37. Baccarani-Contri M, Vincenzi D, Cicchetti F, Mori G, Pasquali-Ronchetti I (1990) Immunocytochemical localization of proteoglycans within normal elastin fi bers. Eur J Cell Biol 53:305-312
38. Gheduzzi D, Guerra D, Bochicchio B, Pepe A, Tamburro AM, Quaglino D, Mithieux S, Weiss AS, Pasquali Ronchetti I (2005) Heparan sulphate interacts with tropoelastin, with some tropoelastin peptides and is present in human Dermis elastic fi bers. Matrix Biol 24:15-25
39. Kozel BA, Ciliberto CH, Mecham RP (2004) Deposition of tropoelastin into the extracellular matrix requires a competent elastic fi ber scaffold but not live cells. Matrix Biol 23:23-34
40. Wagenseil JE, Mecham RP (2012) Elastin in large artery stiffness and hypertension. J Cardiovasc Transl Res 5:264-273
41. Mithieux SM, Weiss AS (2005) Elastin. Adv Protein Chem 70:437-461
42. Chung MI, Miao M, Stahl RJ, Chan E, Parkinson J, Keeley FW (2006) Sequences and domain structures of mammalian, avian, amphibian, and teleost tropoelastins: Clues to the evolutionary history of elastin. Matrix Biol 25:495-504
43. Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS, Keating MT, Li DY (2003) A critical role for elastin signaling in vascular morphogenesis and disease. Development 130:411-423
44. Mecham RP (1998) Overview of extracellular matrix. In: Current protocols in cell biology. Wiley, New York
45. Fung YC (1993) Biomechanics: Mechanical properties of living tissues, 2nd edn. Springer, New York
46. Wagenseil JE, Mecham RP (2009) Vascular extracellular matrix and arterial mechanics. Physiol Rev 89:957-989
47. Kostrominova TY, Brooks SV (2013) Age-related changes in structure and extracellular matrix protein expression levels in rat tendons. Age 35:2203-2214
48. Greenwald SJ (2008) Ageing of the conduit arteries. J Pathol 211:157-172
49. Li Z, Froehlich J, Galis ZS, Lakatta EG (1999) Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 33:116-123
50. Tamarina NA, McMillan WD, Shively VP, Pearce WH (1999) Expression of matrix metalloproteinases and their inhibitors in anuerysm and normal aorta. Surgery 122:264-271
51. Allaire E, Forough R, Clowes M, Starcher B, Clowes AW (1998) Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413-1420
52. Jiang L, Wang M, Zhang J, Monticone RE, Telljohann R, Spinnetti G, Pintus G, Lakatta EG (2008) Increased calpain-1 activity mediates age- Associated angiotensin II signaling of vascular smooth muscle cells. PLoS One 3:e2231
53. Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus- Santos JE (2008) Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis 198:320-331
54. Wolinsky H (1970) Response of the rat aortic media to hypertension. Morphological and chemical studies. Circ Res 26:507-522
55. Todorovich-Hunter L, Johnson D, Ranger P, Keeley F, Rabinovitch M (1988) Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study. Lab Invest 58:184-195
56. O'Connor WN, Davis JB Jr, Geissler R, Cottrill CM, Noonan JA, Todd EP (1985) Supravalvular aortic stenosis. Clinical and pathological observations in six patients. Arch Pathol Lab Med 109:179-185
57. Urban Z, Michels VV, Thibodeau SN, Davis EC, Bonnefont J-P, Munnich A, Eyskens B, Gewillig M, Devriendt K, Boyd CD (2000) Isolated supravalvular aortic stenosis: Functional haploinsuffi ciency of the elastin gene as a result of nonsense-mediated decay. Hum Genet 106:577-588
58. Rodriguez-Revenga L, Iranzo P, Badenas C, Puig S, Carrio A, Mila M (2004) A novel elastin gene mutation resulting in an autosomal dominant from of cutis laxa. Arch Dermatol 149:1135-1139
59. Tassabehji M, Metcalfe K, Hurst J, Ashcroft GS, Kielty C, Wilmot C, Donnai D, Read AP, Jones CJP (1998) An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fi bres in a patient with autodomal dominant cutis laxa. Hum Mol Genet 7:1021-1028
60. Li DY, Brooke D, Davis EC, Mecham RP, Sorensen LK, Boak KK, Eichwald E, Keating MT (1998) Elastin is an essential determinant of arterial morphogenesis. Nature 393:276-289
61. Faury G, Pezet M, Knutsen RH, Boyle WA, Heximer SP, MacLean SE, Minkes RK, Blumer KJ, Kovacs A, Kelly DP, Li DY, Starcher B, Mecham RP (2003) Developmental adaptation of the mouse cardiovascular system to elastin haploinsuffi ciency. J Clin Invest 112:1419-1428
62. Schwill S, Seppelt P, GrÜnhagen J, Ott CE, Jugold M, Ruhparwar A, Robinson PN, Karck M, Kallenbach K (2013) The fi brillin-1 hypomorphic mgR/mgR murine model of Marfan syndrome shows severe elastolysis in all segments of the aorta. J Vasc Surg 57:1628-1636
63. Kielty CM, Sherratt MJ, Marson A, Baldock C (2005) Fibrillin microfi brils. Adv Protein Chem 70:405-436
64. Zhang H, Apfelroth SD, Hu W, Davis EC, Sanguineti C, Bonadio J, Mecham RP, Ramirez F (1994) Structure and expression of fi brillin-2, a novel microfi brillar component preferentially located in elastic matrices. J Cell Biol 124: 855-863
65. Charbonneau NL, Dzamba BJ, Ono RN, Keene DR, Corson GM, Reinhardt DP, Sakai LY (2003) Fibrillins can co-Assemble in fi brils, but fi brillin fi bril composition Displays cell-specifi c differences. J Biol Chem 278:2740-2749
66. Cain SA, Morgan A, Sherratt MJ, Ball SG, Shuttleworth CA, Kielty CM (2006) Proteomic analysis of fi brillinrich microfi brils. Proteomics 6:111-122
67. Robinson PN, Arteaga-Solis E, Baldock C, Collod- Béroud G, Booms P, De Paepe A, Dietz HC, Guo G, Handford PA, Judge DP, Kielty CM, Loeys B, Milewicz DM, Ney A, Ramirez F, Reinhardt DP, Tiedemann K, Whiteman P, Godfrey M (2006) The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43:769-787
68. Milewicz DM, Grossfi eld J, Cao SN, Kielty C, Covitz W, Jewett T (1995) A mutation in FBN1 disrupts profi brillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 95:2373-2378
69. Raghunath M, Putnam EA, Ritty T, Hamstra D, Park ES, Tschodrich-Rotter M, Peters P, Rehemtulla A, Milewicz DM (1999) Carboxy-Terminal conversion of profi brillin to fi brillin at a basic site by PACE/ furin-like activity required for incorporation in the matrix. J Cell Sci 112:1093-1100
70. Hubmacher D, Sabatier L, Annis DS, Mosher DF, Reinhardt DP (2011) Homocysteine modifi es structural and functional properties of fi bronectin and interferes with the fi bronectin-fi brillin-1 interaction. Biochemistry 50:5322-5332
71. Yanagisawa H, Davis EC (2010) Unraveling the mechanism of elastic fi ber assembly: The roles of short fi bulins. Int J Biochem Cell Biol 42:1084-1093
72. Wachi H, Nonaka R, Sato F, Shibata-Sato K, Ishida M, Iketani S, Maeda I, Okamoto K, Urban Z, Onoue S, Seyama Y (2008) Characterization of the molecular interaction between tropoelastin and DANCE/ fi bulin-5. J Biochem 143:633-639
73. Hambleton S, Valeyev NV, Muranyi A, Knott V, Werner JM, McMichael AJ, Handford PA, Downing AK (2004) Structural and functional properties of the human notch-1 ligand binding region. Structure 12:2173-2183
74. Yanagisawa H, Schluterman MK, Brekken RA (2009) Fibulin-5, an integrin-binding matricellular protein: Its function in Development and disease. J Cell Commun Signal 3:337-347
75. Zheng Q, Davis EC, Richardson JA, Starcher BC, Li T, Gerard RD, Yanagisawa H (2007) Molecular analysis of fi bulin-5 function During de novo synthesis of elastic fi bers. Mol Cell Biol 27:1083-1095
76. Hirai M, Ohbayashi T, Horiguchi M, Okawa K, Hagiwara A, Chien KR, Kita T, Nakamura T (2007) Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J Cell Biol 176:1061-1071
77. Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, Yanagisawa H, Zuo J, Li T (2004) Elastic fi ber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet 36:178-182
78. Horiguchi M, Inoue T, Ohbayashi T, Hirai M, Noda K, Marmorstein LY, Yabe D, Takagi K, Akama TO, Kita T, Kimura T, Nakamura T (2009) Fibulin-4 conducts proper elastogenesis via interaction with crosslinking enzyme lysyl oxidase. Proc Natl Acad Sci U S A 106:19029-19034
79. Sato F, Wachi H, Ishida M, Nonaka R, Onoue S, Urban Z, Starcher BC, Seyama Y (2007) Distinct steps of cross-linking, self-Association, and maturation of tropoelastin are necessary for elastic fi ber formation. J Mol Biol 369:841-851
80. Klenotic PA, Munier FL, Marmorstein LY, Anand- Apte B (2004) Tissue inhibitor of metalloproteinase- 3 (TIMP-3) is a binding partner of epithelial growth factor-containing fi bulin-like extracellular matrix protein 1 (EFEMP1): Implications for macular degenerations. J Biol Chem 279:30469-30473
81. Ramirez F, Dietz HC (2007) Fibrillin-rich microfi - brils: Structural determinants of morphogenetic and homeostatic events. J Cell Physiol 213:326-330
82. DeVega A, Iwamoto T, Yamada Y (2009) Fibulins: Multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 66:1890-1902
83. Zhang HY, Timpl R, Sasaki T, Chu ML, Ekblom P (1996) Fibulin-1 and fi bulin-2 expression During organogenesis in the developing mouse embryo. Dev Dyn 205:348-364
84. Tsuda T, Wang H, Timpl R, Chu ML (2001) Fibulin-2 expression marks transformed mesenchymal cells in Developing cardiac valves, aortic arch vessels and coronary vessels. Dev Dyn 222:89-100
85. Tucker RP, Drabikowski K, Hess JF, Ferralli J, Chiquet-Ehrismann R, Adams JC (2006) Phylogenetic analysis of the tenascin gene family: Evidence of origin early in the chordate lineage. BMC Evol Biol 6:60
86. Tucker RP, Chiquet-Ehrismann R (2009) The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 1793:888-892
87. Okamoto H, Imanaka-Yoshida K (2012) Matricellular proteins: New molecular targets to prevent heart failure. Cardiovasc Ther 30:e198-e209
88. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M (1988) Tenascin interferes with fi bronectin action. Cell 53:383-390
89. Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo V, Orend G (2001) Interference of tenascin-C with syndecan-4 binding to fi bronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res 61:8586-8594
90. Midwood KS, Schwarzbauer JS (2002) Tenascin-C modulates matrix contraction via focal adhesion kinase- And Rho-mediated signaling pathways. Mol Biol Cell 13:3601-3613
91. Chiquet-Ehrismann R, Chiquet M (2003) Regulation and putative functions during pathological stress. J Pathol 200:488-499
92. Jones FS, Jones PL (2000) The tenascin family of ECM glycoproteins: Structure, function, and regulation During embryonic development and tissue remodeling. Dev Dyn 218:235-259
93. Kreja L, Liedert A, Schlenker H, Brenner RE, Fiedler J, Friemert B, DÜrselen L, Ignatius A (2012) Effects of mechanical strain on human mesenchymal stem cells and ligament fi broblasts in a textured poly(L-lactide) scaffold for ligament tissue engineering. J Mater Sci Mater Med 23:2575-2582
94. Järvinen TA, Józsa L, Kannus P, Järvinen TL, Hurme T, Kvist M, Pelto-Huikko M, Kalimo H, Järvinen M (2003) Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci 116:857-866
95. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, Weller A, BÜhler FR (1992) Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 141:377-388
96. Page TH, Charles PJ, Piccinini AM, Nicolaidou V, Taylor PC, Midwood KS (2012) Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther 14:R260
97. Chockalingam PS, Glasson SS, Lohmander LS (2013) Tenascin-C levels in synovial fl uid are elevated after injury to the human and canine joint and correlate with markers of infl ammation and matrix degradation. Osteoarthritis Cartilage 21:339-345
98. Imanaka-Yoshida K (2012) Tenascin-C in cardiovascular tissue remodeling: From development to infl ammation and repair. Circ J 76:2513-2520
99. Midwood KS, Hussenet T, Langlois B, Orend G (2011) Advances in tenascin-C biology. Cell Mol Life Sci 68:3175-3199
100. Perrotta I, Russo E, Camastra C, Filice G, Di Mizio G, Colosimo F, Ricci P, Tripepi S, Amorosi A, Triumbari F, Donato G (2011) New evidence for a critical role of elastin in calcifi cation of native heart valves: Immunohistochemical and ultrastructural study with literature review. Histopathology 59:504-513
101. FlÜck M, Tunc-Civelek V, Chiquet M (2000) Rapid and reciprocal regulation of tenascin-C and tenascin- Y expression by loading of skeletal muscle. J Cell Sci 113:3583-3591
102. Chiquet M, Gelman L, Lutz R, Maier S (2009) From mechanostransduction to extracellular matrix gene expression in fi broblasts. Biochim Biophys Acta 1793:911-920
103. Hagios C, Koch M, Spring J, Chiquet M, Chiquet- Ehrismann R (1996) Tenascin-Y: A protein of novel domain structure is secreted by differentiated fi broblasts of muscle connective tissue. J Cell Biol 134:1499-1512
104. Berndt A, Kosmehl H, Katenkamp D, Tauchmann V (1994) Appearance of the myofi broblastic phenotype in Dupuytren's disease is associated with a fi bronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 62:55-58
105. Mackey AL, Brandstetter S, Schjerling P, Bojsen- Moller J, Qvortrup K, Pedersen MM, Doessing S, Kjaer M, Magnusson SP, Langberg H (2011) Sequences response of extracellular matrix deadhesion and fi brotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle. FASEB J 25:1943-1959
106. FlÜck M, Mund SI, Schittny JC, Klossner S, Durieux AC, Giraud MN (2008) Mechano-regulated tenascin- C orchestrates muscle repair. Proc Natl Acad Sci U S A 105:13662-13667
107. Murphy-Ullrich JE, Iozzo RV (2012) Thrombospondins in physiology and disease: New tricks for old dogs. Matrix Biol 31:152-154
108. Adams JC, Lawler J (2004) The thrombospondins. Int J Biochem Cell Biol 36:961-968
109. Adams JC, Lawler J (2011) The thrombospondins. Cold Spring Harb Perspect Biol 3:a00971
110. Mosher DF, Adams JC (2012) Adhesion-modulating/ matricellular ECM protein families: A structural, functional and evolutionary appraisal. Matrix Biol 31:155-161
111. Lu A, Miao M, Schoeb TR, Agarwal A, Murphy- Ullrich JE (2011) Blockade of TSP-1 dependent TGF-beta activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am J Pathol 178:2573-2586
112. Belmadani S, Bernal J, Wei CC, Pallero MA, Dell'italia L, Murphy-Ullrich JE, Brecek KH (2007) A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 171:777-789
113. Chipev CC, Simman R, Hatch G, Katz AE, Siegel DM, Simon M (2000) Myofi broblast phenotype and apoptosis in keloid and palmar fi broblasts in vitro. Cell Death Differ 7:166-176
114. Mimura Y, Ihn H, Jinnin M, Assano Y, Yamane K, Tamaki K (2005) Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fi broblasts. Am J Pathol 166:1451-1463
115. Sweetwyne MT, Murphy-Ullrich JE (2012) Thrombospondin1 in tissue repair and fi brosis: TGF- β- dependent and independent mechanisms. Matrix Biol 31:178-186
116. Rogers NM, Yao M, Novelli EM, Thomson AW, Roberts DD, Isenberg JS (2012) Activated CD47 regulates multiple vascular and stress responses: Implications for acute kidney injury and its management. Am J Physiol Renal Physiol 303:F1117-F1125
117. Agah A, Kyriakides TR, Lawler J, Bornstein P (2002) The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in Double-TSP1/ TSP/2-null mice. Am J Pathol 161:831-839
118. Hohenstein B, Daniel C, Hausknecht B, Boehmer K, Riess R, Amann KU, Hugo CP (2008) Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling, and proteinuria in human type-2 diabetic nephropathy. Nephrol Dial Transplant 23:3880-3887
119. Chandrasekaran S, Guo NH, Rodrigues RG, Kaiser J, Roberts DD (1999) Pro-Adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98. J Biol Chem 274:11408-11416
120. Chen H, Sottile J, Strickland DK, Mosher DF (1996) Binding and degradation of thrombospondin-1 mediated through heparan sulfate proteoglucans and low-density-lipoprotein receptor-related protein: Localization of the functional activity to the trimeric N-Terminal heparin-binding region of thrombospondin-1. Biochem J 318:959-963
121. Murphy-Ullrich JE, Poczatek M (2000) Activation of latent TGF-beta by thrombospondin-1: Mechanism and physiology. Cytokine Growth Factor Rev 11:59-69
122. Elzie CA, Murphy-Ullrich JE (2004) The N-Terminus of thrombospondin: The domain stands apart. Int J Biochem Cell Biol 36:1090-1101
123. Goldblum SE, Young BA, Wang P, Murphy-Ullrich JE (1999) Thrombospondin-1 induces tyrosine phosphorylation of adherens junction proteins and regulates an endothelial paracellular pathway. Mol Biol Cell 10:1537-1551
124. Robert DD, Miller TW, Rogers NM, Yao M, Isenberg JS (2012) The matricellular protein thrombospondin- 1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biol 31:162-169
125. Hess D, Keusch JJ, Lesnik Oberstein SA, Hennekam RC, Hofsteenge J (2008) Peter plus syndrome is a new congenital disorder of glycosylation and involves defective O-glycosylation of thrombospondin type 1 repeats. J Biol Chem 283:7354-7360
126. Heinonen TY, Maki M (2009) Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifi es thrombospondin type 1 repeats. Ann Med 41:2-10
127. Shimizu R, Saito R, Hoshino K, Ogawa K, Negishi T, Nishimura J, Mitsui N, Osawa M, Ohashi H (2010) Severe Peters Plus syndrome-like phenotype with anterior eye staphyloma and hypoplastic left heart syndrome: Proposal of a new syndrome. Congenit Anom (Kyoto) 50:197-199
128. Hanna NN, Eickholt K, Agamanolis D, Burnstine R, Edward DP (2010) Atypical Peters plus syndrome with new associations. J AAPOS 14:181-183
129. Eberwein P, Reinhard T, Agostini H, Poloschek CM, Guthoff R, Auw-Haedrich C (2010) Intensive intracorneal keloid formation in a case of Peters plus syndrome and in Peters anomaly with maximum manifestation. Ophthalmologe 107:178-181
130. Oldberg Å, Antonssen P, Lindholm K, Heinegård D (1992) COMP (cartilage oligomeric matrix protein) is structurally related to thrombospondins. J Biol Chem 267:22346-22350
131. Rock MJ, Holden P, Horton WA, Cohn DH (2010) Cartilage oligometric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and aVβ3 integrin. Mol Cell Biochem 338:215-224
132. Holden P, Meadows RS, Chapman KL, Grant ME, Kadler KE, Briggs MD (2001) Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 276:6046-6055
133. Rosenberg K, Olsson H, Mörgelin M, Heinegård D (1998) Cartilage oligomeric matrix protein shows high affi nity zinc-dependent interaction with triple helical collagen. J Biol Chem 273:20397-20403
134. Di Cesare P, Hauser N, Lehman D, Pasumarti S, Paulsson M (1994) Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 354:237-240
135. Heinegård D (2009) Proteoglycans and more - from molecules to biology. Int J Exp Path 70:575-586
136. Smith RKW, Zunino L, Webbon PM, Heinegård D (1997) The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 16:255-271
137. Södersten F, Hultenby K, Heinegård D, Johnston C, Ekman S (2013) Immunolocalization of collagens (I and III) and cartilage oligomeric matrix protein in the normal and injured equine superfi cial digital fl exor tendon. Connect Tissue Res 54:62-69
138. Halasz K, Kassner A, Morgelin M, Heinegård D (2007) COMP as a catalyst in collagen fi brillogenesis. J Biol Chem 282:31166-31173
139. Hesselstrand R, Kassner A, Heinegård D, Saxne T (2008) COMP: A candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker. Ann Rheum Dis 67:1242-1248
140. Smith MR, Wright IM, Minshall GJ, Dudhia J, Verheyen K, Heinegård D, Smith RK (2011) Increased cartilage oligomeric matrix protein concentrations in equine digital fl exor tendon sheath synovial fl uid predicts interthecal tendon Damage. Vet Surg 40:54-58
141. Wang L, Wang X, Kong W (2010) ADAMTS-7, a novel proteolytic culprit in vascular remodeling. Sheng Li Xue Bao 62:285-294
142. Riessen R, Fenchel M, Chen H, Axel DL, Karsch KR, Lawler J (2001) Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21:47-54
143. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN (1994) Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144:962-974
144. Du Y, Wang Y, Wang L, Liu B, Tian Q, Liu CJ, Zhang T, Xu Q, Zhu Y, Ake O, Qi Y, Tang C, Kong W, Wang X (2011) Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcifi cation by interacting with bone morphogenetic protein-2. Circ Res 108:917-928
145. Posey KL, Hecht JT (2008) The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets 9:869-877